- Home
- JILL vs ABEO Comparison
JILL vs ABEO Comparison
Compare JILL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- ABEO
- Stock Information
- Founded
- JILL 1959
- ABEO 1974
- Country
- JILL United States
- ABEO United States
- Employees
- JILL N/A
- ABEO N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- JILL Consumer Discretionary
- ABEO Health Care
- Exchange
- JILL Nasdaq
- ABEO Nasdaq
- Market Cap
- JILL 233.1M
- ABEO 256.9M
- IPO Year
- JILL 2017
- ABEO 1980
- Fundamental
- Price
- JILL $14.91
- ABEO $5.76
- Analyst Decision
- JILL Buy
- ABEO Strong Buy
- Analyst Count
- JILL 4
- ABEO 6
- Target Price
- JILL $29.75
- ABEO $18.00
- AVG Volume (30 Days)
- JILL 184.8K
- ABEO 1.1M
- Earning Date
- JILL 06-11-2025
- ABEO 08-11-2025
- Dividend Yield
- JILL 2.17%
- ABEO N/A
- EPS Growth
- JILL N/A
- ABEO N/A
- EPS
- JILL 2.24
- ABEO N/A
- Revenue
- JILL $602,968,000.00
- ABEO N/A
- Revenue This Year
- JILL $1.16
- ABEO N/A
- Revenue Next Year
- JILL $2.58
- ABEO $323.51
- P/E Ratio
- JILL $6.57
- ABEO N/A
- Revenue Growth
- JILL N/A
- ABEO N/A
- 52 Week Low
- JILL $13.36
- ABEO $3.93
- 52 Week High
- JILL $40.00
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- JILL 44.54
- ABEO 45.63
- Support Level
- JILL $13.53
- ABEO $5.66
- Resistance Level
- JILL $15.01
- ABEO $6.24
- Average True Range (ATR)
- JILL 0.76
- ABEO 0.29
- MACD
- JILL -0.02
- ABEO -0.07
- Stochastic Oscillator
- JILL 27.39
- ABEO 20.34
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.